To identify the molecule targeted by C1q during HCC progression, we treated HepG2 cells with or without C1q and evaluated the expressions of DDRs and of the well-known C1q receptors, gC1qR and cC1qR. Here, C1QBP is linked to hepatocellular carcinoma.